Hjem › Multipelt myelom › Minnesota › Minneapolis
Kliniske studier for Multipelt myelom i Minneapolis, MN
11 studier for Multipelt myelom søker deltakere på steder i og rundt Minneapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University Of Minnesota Medical Center, Minneapolis
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekruttererFase 2/3
- Minnesota Oncology - Minneapolis Clinic /ID# 278720, Minneapolis
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekruttererFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi unna
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekruttererFase 1/2
- Research Site, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RekruttererFase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruttererFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- og 1 flere
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Rekrutterer
- University of Minnesota - Masonic Cancer Center, Minneapolis
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruttererFase 2
- Minnesota Oncology Hematology, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Allina Health Cancer Institute, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RekruttererFase 1/2
- University of Minnesota, Minneapolis
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
RekruttererObservasjonsstudie
- Center for International Blood and Marrow Transplant Research, Minneapolis
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Minneapolis
- Brystkreft27 studier
- Ikke-småcellet lungekreft26 studier
- Eggstokkreft24 studier
- Prostatakreft23 studier
- Kreft (alle typer)22 studier
- Hjertesvikt21 studier
- Lungekreft20 studier
- Akut myelogen leukemi20 studier
- Kolorektal kreft19 studier
- Endometriekreft18 studier
- Parkinsons sykdom17 studier
- Kardiovaskulær sykdom15 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.